Thursday 25 June: 14:00-16:00 CET
Zoomlink follows
Chair: Rudolf de Boer
Introduction session by Rudolf de Boer (UMCG)
C. Stehouwer (Maastricht): “Diabetes and CV disease: vicious twins”
S. Dolleman (LUMC): “Impact of DOACs on microvascular destabilization in AF”
C. Tack (Radboud): “Metformin: first line drug or overdue?”
| D. Westenbrink (UMCG): “SGLT2 inhibitors: mode of mechanism and CVOTs” |